# Jonathan Barratt

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jonathan-barratt/

## Facts

| Field | Value |
| --- | --- |
| Citations | 25,439 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 80 |
| i10-index | 220 |
| Last Known Institution | University of Leicester |
| OpenAlex ID | https://openalex.org/A5055078486 |
| ORCID iD | 0000-0002-9063-7229 |
| Works | 601 |

## Researcher papers

Showing 12 of 34.

- [KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases](https://scholariq.org/papers/kdigo-2021-clinical-practice-guideline-for-the-management-of-glomerular-diseases/)
- [The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification](https://scholariq.org/papers/the-oxford-classification-of-iga-nephropathy-rationale-clinicopathological/)
- [Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group](https://scholariq.org/papers/oxford-classification-of-iga-nephropathy-2016-an-update-from-the-iga-nephropathy/)
- [The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility](https://scholariq.org/papers/the-oxford-classification-of-iga-nephropathy-pathology-definitions-correlations/)
- [Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases](https://scholariq.org/papers/executive-summary-of-the-kdigo-2021-guideline-for-the-management-of-glomerular/)
- [Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens](https://scholariq.org/papers/discovery-of-new-risk-loci-for-iga-nephropathy-implicates-genes-involved-in/)
- [Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments](https://scholariq.org/papers/validation-of-the-oxford-classification-of-iga-nephropathy-in-cohorts-with/)
- [Long-Term Outcomes in IgA Nephropathy](https://scholariq.org/papers/long-term-outcomes-in-iga-nephropathy/)
- [Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial](https://scholariq.org/papers/targeted-release-budesonide-versus-placebo-in-patients-with-iga-nephropathy/)
- [IgA Nephropathy](https://scholariq.org/papers/iga-nephropathy-3/)
- [Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: Observations in three patients](https://scholariq.org/papers/mesangial-iga1-in-iga-nephropathy-exhibits-aberrant-o-glycosylation-observations/)
- [A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy](https://scholariq.org/papers/a-multicenter-study-of-the-predictive-value-of-crescents-in-iga-nephropathy/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)

## Researcher university

- [University of Leicester](https://scholariq.org/institutions/university-of-leicester/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.